For investors willing to look beyond the obvious names, this portion of the EV sector offers a quiet yet potentially ...

Key Points - GAAP EPS of $0.24 topped analyst estimates by 4.4% in Q2 2025, with GAAP revenue beating estimates by 6.5% in Q2 2025 - Net interest margin expanded to 2.57%, up from 2.09% a year earlier ...

Brokerages expect steady revenue growth for Dr Reddy’s in Q1FY26, but caution that US price erosion and product mix could ...

Cipla is expected to post muted profit growth for Q1FY26 despite steady revenue momentum, with US sales remaining flat and ...

ASML is powering important advancements in artificial intelligence. Alternatively, you can invest in a company like ASML ...

Automotive manufacturer General Motors (NYSE:GM) beat Wall Street’s revenue expectations in Q2 CY2025, but sales fell by 1.8% year on year to $47.12 billion. Its non-GAAP profit of $2.53 per share was ...

MEXICO CITY (Reuters) -Shares in Becle, the world's largest tequila producer, surged over 7% on Thursday after it reported a ...

Hogan had hit peak stardom, and crossed over into starring in movies. He played a wrestler in “No Holds Barred” (1989) and an ...

Leading pharmaceutical major Dr Reddys Laboratories is set to announce its Q1FY26 financial results on. Markets top analysts ...

WEATHERSFIELD — Brattleboro Union High School alum Brian Lashway claimed the top spot at the Southern Vermont Decathlon for ...

Pharmaceutical major Dr. Reddys Laboratories reported its financial results for the first quarter (Q1) of FY26 on Thursday, ...

Infosys reported 8.7% rise in Q1 profit to Rs 6,921 crore and raised lower end of FY25 revenue guidance to 1%, backed by $3.8 ...